SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001136261-18-000211
Filing Date
2018-08-09
Accepted
2018-08-09 16:20:44
Documents
69
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q body10q.htm 10-Q 831497
2 CEO 302 CERTIFICATE exh31-1.htm EX-31.1 5011
3 CFO 302 CERTIFICATE exh31-2.htm EX-31.2 4797
4 906 CERTIFICATE exh32-1.htm EX-32.1 3287
5 LOGO image1904.jpg GRAPHIC 6415
  Complete submission text file 0001136261-18-000211.txt   4119313

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ptx-20180630.xml EX-101.INS 789411
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ptx-20180630.xsd EX-101.SCH 45767
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ptx-20180630_cal.xml EX-101.CAL 66392
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ptx-20180630_def.xml EX-101.DEF 113032
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ptx-20180630_lab.xml EX-101.LAB 369023
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ptx-20180630_pre.xml EX-101.PRE 264461
Mailing Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960
Business Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960 (862) 260-8457
PERNIX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001024126 (see all company filings)

IRS No.: 330724736 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14494 | Film No.: 181005334
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences